Posted by Michael Wonder on 16 Feb 2026
neffy, adrenaline nasal spray, now approved to treat anaphylaxis in Australia
16 February 2026 - CSL Seqirus has today announced that neffy adrenaline (epinephrine) nasal spray is now available and has been approved for use in Australia for the emergency treatment of anaphylaxis in adults and children 15kg+ and aged four years and over.
CSL has submitted an application for neffy to be subsidised and listed on the PBS. The submission will be considered in March 2026.
